These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
197 related items for PubMed ID: 19965779
1. Pharmacological inhibition of C-C chemokine receptor 2 decreases macrophage infiltration in the aortic root of the human C-C chemokine receptor 2/apolipoprotein E-/- mouse: magnetic resonance imaging assessment. Olzinski AR, Turner GH, Bernard RE, Karr H, Cornejo CA, Aravindhan K, Hoang B, Ringenberg MA, Qin P, Goodman KB, Willette RN, Macphee CH, Jucker BM, Sehon CA, Gough PJ. Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):253-9. PubMed ID: 19965779 [Abstract] [Full Text] [Related]
2. Anti-inflammatory drug evaluation in ApoE-/- mice by ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging. Sigovan M, Kaye E, Lancelot E, Corot C, Provost N, Majd Z, Breisse M, Canet-Soulas E. Invest Radiol; 2012 Sep; 47(9):546-52. PubMed ID: 22864378 [Abstract] [Full Text] [Related]
3. p38 MAPK inhibition reduces aortic ultrasmall superparamagnetic iron oxide uptake in a mouse model of atherosclerosis: MRI assessment. Morris JB, Olzinski AR, Bernard RE, Aravindhan K, Mirabile RC, Boyce R, Willette RN, Jucker BM. Arterioscler Thromb Vasc Biol; 2008 Feb; 28(2):265-71. PubMed ID: 18162612 [Abstract] [Full Text] [Related]
4. Assessment of macrophage infiltration in a murine model of abdominal aortic aneurysm. Turner GH, Olzinski AR, Bernard RE, Aravindhan K, Boyle RJ, Newman MJ, Gardner SD, Willette RN, Gough PJ, Jucker BM. J Magn Reson Imaging; 2009 Aug; 30(2):455-60. PubMed ID: 19629967 [Abstract] [Full Text] [Related]
5. Melatonin inhibits macrophage infiltration and promotes plaque stabilization by upregulating anti-inflammatory HGF/c-Met system in the atherosclerotic rabbit: USPIO-enhanced MRI assessment. Hu ZP, Fang XL, Sheng B, Guo Y, Yu YQ. Vascul Pharmacol; 2020 Apr; 127():106659. PubMed ID: 32068091 [Abstract] [Full Text] [Related]
6. Development of a magnetic resonance imaging protocol for the characterization of atherosclerotic plaque by using vascular cell adhesion molecule-1 and apoptosis-targeted ultrasmall superparamagnetic iron oxide derivatives. Burtea C, Ballet S, Laurent S, Rousseaux O, Dencausse A, Gonzalez W, Port M, Corot C, Vander Elst L, Muller RN. Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):e36-48. PubMed ID: 22516067 [Abstract] [Full Text] [Related]
7. Everolimus limits aortic aneurysm in the apolipoprotein E-deficient mouse by downregulating C-C chemokine receptor 2 positive monocytes. Moran CS, Jose RJ, Moxon JV, Roomberg A, Norman PE, Rush C, Körner H, Golledge J. Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):814-21. PubMed ID: 23393391 [Abstract] [Full Text] [Related]
8. [Value of in vivo monitoring of abdominal aortic atherosclerosis by high field magnetic resonance imaging in apoE-/- mice fed a high fat diet or infused with angiotensin II]. ZHAO R, YAO YY, DENG G, JU SH, WANG ZJ, WEN S, CHEN J, JIN H. Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Sep; 38(9):823-8. PubMed ID: 21092653 [Abstract] [Full Text] [Related]
9. A leukocyte-mimetic magnetic resonance imaging contrast agent homes rapidly to activated endothelium and tracks with atherosclerotic lesion macrophage content. McAteer MA, Mankia K, Ruparelia N, Jefferson A, Nugent HB, Stork LA, Channon KM, Schneider JE, Choudhury RP. Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1427-35. PubMed ID: 22499989 [Abstract] [Full Text] [Related]
10. Pharmacological inhibition of the chemokine receptor, CX3CR1, reduces atherosclerosis in mice. Poupel L, Boissonnas A, Hermand P, Dorgham K, Guyon E, Auvynet C, Charles FS, Lesnik P, Deterre P, Combadiere C. Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2297-305. PubMed ID: 23887641 [Abstract] [Full Text] [Related]
11. Deficiency in lymphotoxin β receptor protects from atherosclerosis in apoE-deficient mice. Grandoch M, Feldmann K, Göthert JR, Dick LS, Homann S, Klatt C, Bayer JK, Waldheim JN, Rabausch B, Nagy N, Oberhuber A, Deenen R, Köhrer K, Lehr S, Homey B, Pfeffer K, Fischer JW. Circ Res; 2015 Apr 10; 116(8):e57-68. PubMed ID: 25740843 [Abstract] [Full Text] [Related]
12. Corosolic acid ameliorates atherosclerosis in apolipoprotein E-deficient mice by regulating the nuclear factor-κB signaling pathway and inhibiting monocyte chemoattractant protein-1 expression. Chen H, Yang J, Zhang Q, Chen LH, Wang Q. Circ J; 2012 Apr 10; 76(4):995-1003. PubMed ID: 22293444 [Abstract] [Full Text] [Related]
13. Visualization of vascular inflammation in the atherosclerotic mouse by ultrasmall superparamagnetic iron oxide vascular cell adhesion molecule-1-specific nanoparticles. Michalska M, Machtoub L, Manthey HD, Bauer E, Herold V, Krohne G, Lykowsky G, Hildenbrand M, Kampf T, Jakob P, Zernecke A, Bauer WR. Arterioscler Thromb Vasc Biol; 2012 Oct 10; 32(10):2350-7. PubMed ID: 22879583 [Abstract] [Full Text] [Related]
14. The ATHEROMA (Atorvastatin Therapy: Effects on Reduction of Macrophage Activity) Study. Evaluation using ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging in carotid disease. Tang TY, Howarth SP, Miller SR, Graves MJ, Patterson AJ, U-King-Im JM, Li ZY, Walsh SR, Brown AP, Kirkpatrick PJ, Warburton EA, Hayes PD, Varty K, Boyle JR, Gaunt ME, Zalewski A, Gillard JH. J Am Coll Cardiol; 2009 Jun 02; 53(22):2039-50. PubMed ID: 19477353 [Abstract] [Full Text] [Related]
15. Differential uptake of ferumoxtran-10 and ferumoxytol, ultrasmall superparamagnetic iron oxide contrast agents in rabbit: critical determinants of atherosclerotic plaque labeling. Yancy AD, Olzinski AR, Hu TC, Lenhard SC, Aravindhan K, Gruver SM, Jacobs PM, Willette RN, Jucker BM. J Magn Reson Imaging; 2005 Apr 02; 21(4):432-42. PubMed ID: 15779033 [Abstract] [Full Text] [Related]
16. Negative MR contrast caused by USPIO uptake in lymph nodes may lead to false positive observations with in vivo visualization of murine atherosclerotic plaque. te Boekhorst BC, Bovens SM, Nederhoff MG, van de Kolk KW, Cramer MJ, van Oosterhout MF, Ten Hove M, Doevendans PA, Pasterkamp G, van Echteld CJ. Atherosclerosis; 2010 May 02; 210(1):122-9. PubMed ID: 19939385 [Abstract] [Full Text] [Related]
17. Scavenger receptor-AI-targeted iron oxide nanoparticles for in vivo MRI detection of atherosclerotic lesions. Segers FM, den Adel B, Bot I, van der Graaf LM, van der Veer EP, Gonzalez W, Raynal I, de Winther M, Wodzig WK, Poelmann RE, van Berkel TJ, van der Weerd L, Biessen EA. Arterioscler Thromb Vasc Biol; 2013 Aug 02; 33(8):1812-9. PubMed ID: 23744990 [Abstract] [Full Text] [Related]
18. Chronic infusion of salusin-alpha and -beta exerts opposite effects on atherosclerotic lesion development in apolipoprotein E-deficient mice. Nagashima M, Watanabe T, Shiraishi Y, Morita R, Terasaki M, Arita S, Hongo S, Sato K, Shichiri M, Miyazaki A, Hirano T. Atherosclerosis; 2010 Sep 02; 212(1):70-7. PubMed ID: 20684826 [Abstract] [Full Text] [Related]
19. Imaging monocytes with iron oxide nanoparticles targeted towards the monocyte integrin MAC-1 (CD11b/CD18) does not result in improved atherosclerotic plaque detection by in vivo MRI. von zur Muhlen C, Fink-Petri A, Salaklang J, Paul D, Neudorfer I, Berti V, Merkle A, Peter K, Bode C, von Elverfeldt D. Contrast Media Mol Imaging; 2010 Sep 02; 5(5):268-75. PubMed ID: 20973112 [Abstract] [Full Text] [Related]
20. Pharmacological activation of the melanocortin system limits plaque inflammation and ameliorates vascular dysfunction in atherosclerotic mice. Rinne P, Silvola JM, Hellberg S, Ståhle M, Liljenbäck H, Salomäki H, Koskinen E, Nuutinen S, Saukko P, Knuuti J, Saraste A, Roivainen A, Savontaus E. Arterioscler Thromb Vasc Biol; 2014 Jul 02; 34(7):1346-54. PubMed ID: 24790139 [Abstract] [Full Text] [Related] Page: [Next] [New Search]